Growth and cell cycle abnormalities of fibroblasts from Tangier disease patients

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 1, 1999, Pages 28-38

  Drobnik, Wolfgang ^a   Liebisch, Gerhard ^a   Biederer, Carola ^a   Trümbach, Barbara ^a   Rogler, Gerhard ^a   Müller, Peter ^a   Schmitz, Gerd ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Cell cycle; Ceramide; Cholesterol efflux; Golgi apparatus; Tangier disease

Indexed keywords

2 DECANOYLAMINO 3 MORPHOLINO 1 PHENYL 1 PROPANOL; GUANINE NUCLEOTIDE BINDING PROTEIN; HIGH DENSITY LIPOPROTEIN; PHOSPHOLIPASE D;

ADULT; ARTICLE; CASE REPORT; CELL PROLIFERATION; FEMALE; GOLGI COMPLEX; GROWTH REGULATION; HUMAN; INTRACELLULAR TRANSPORT; LIPID TRANSPORT; MALE; MITOGENICITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TANGIER DISEASE;

EID: 0032895281     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.1.28     Document Type: Article

References (51)

1. Assmann G, Schmitz G, Brewer HB Jr. Familial HDL deficiency: Tangier disease. In: Scriver CR, Beaudet AS, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease. 6th ed. New York, NY: McGraw-Hill Book Co; 1989:1267-1282.
2. Glickman RM, Grenn PHR, Lees RS, Tall A. Apoprotein A-I synthesis in normal intestinal mucosa and in Tangier disease. N Engl J Med. 1978; 299:1424-1427.
3. Bojanovski D, Gregg RE, Zech LA, Meng MS, Bishop C, Ronan R, Brewer HB Jr. In vivo metabolism of proapolipoprotein A-I in Tangier disease. J Clin Invest. 1987;80:1742-1747.
4. Schmitz G, Robenek H, Lohmann U, Assmann G. Interaction of high density lipoproteins with cholesteryl ester laden macrophages: biochemical and morphological characterization of cell surface binding, endocytosis and resecretion of high density lipoproteins by macrophages. EMBO J. 1985;4:613-622.
5. Schmitz G, Assmann G, Robenek H, Brennhausen B. Tangier disease: a disorder of intracellular membrane traffic. Proc Natl Acad Sci U S A. 1985;82:6305-6309.
6. Robenek H, Schmitz G. Abnormal processing of Golgi elements and lysosomes in Tangier disease. Arterioscler Thromb. 1991;11:1007-1020.
7. Regler G, Trümbach B, Klima B, Lackner KJ, Schmitz G. High density lipoprotein-mediated efflux of newly synthesized cholesterol is impaired in fibroblasts from Tangier patients while membrane description and efflux of lysosomal cholesterol are normal. Arterioscler Thromh Vasc Biol. 1995;15:683-690.
8. Francis GA, Knopp RH, Oram JF. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier disease. J Clin Invest. 1995;96:78-87.
9. Walter M, Gerdes U, Seedorf U, Assmann G. The high density lipoprotein-and apolipoprotein A-I-induced mobilization of cellular cholesterol is impaired in fibroblasts from Tangier disease subjects. Biochem Biophys Res Commun. 1994;205:850-856.
10. Pappu AS, Hauser G. Propranolol-induced inhibition of rat brain cytoplasmic phosphatidate phosphohydrolase. Neurochem Res. 1983;8: 1565-1575.
11. Drobnik W, Möllers C, Resink T, Schmitz G. Activation of phosphatidylinositol-specific phospholipase C in response to high density and low density lipoproteins is markedly reduced in cultured fibroblasts from Tangier patients. Arterioscler Thromb Vasc Biol. 1995;15: 1369-1377.
12. Möllers C, Drobnik W, Resink T, Schmitz G. High density and low density lipoprotein-mediated signal transduction in cultured human skin fibroblasts. Cell Signal. 1995;7:695-707.
13. Walter M, Reinecke H, Gerdes U, Nofer J-R, Höbbel G, Seedorf U, Assmann G. Defective regulation of phosphatidylcholine-specific phospholipase C and D in a kindred with Tangier disease. J Clin Invest. 1996;98:2315-2323.
14. Martin TFJ. Greasing the Golgi budding machine. Nature. 1997;387:21-22.
15. Ohashi M, Jan-de-Vries K, Frank R, Snoek G, Bankaitis V, Wirtz K, Huttner WB. A role for phosphatidylinositol transfer protein in secretory vesicle formation. Nature. 1995;377:544-547.
16. Alb JG, Kearns MA, Bankaitis VA. Phospholipid metabolism and membrane dynamics. Curr Opin Cell Biol. 1996;8:534-541.
17. Cunningham E, Thomas GM, Ball A, Hiles I, Cockcroft S. Phosphatidylinositol transfer protein dictates the rate of inositol trisphosphate production by promoting the synthesis of PIP2. Curr Biol. 1995;5: 775-783.
18. Yokozeki T, Kuribara H, Katada T, Touhara K, Kanaho Y. Partially purified RhoA-stimulated phospholipase D activity specifically binds to phosphatidylinositol 4,5-bisphosphate. J Neurochem. 1996;66: 1234-1239.
19. Ktistakis NT, Brown HA, Waters MG, Sternweis PC, Roth MG. Evidence that phospholipase D mediates ADP ribosylation factor-dependent formation of Golgi coated vesicles. J Cell Biol. 1996;134:295-306.
20. Schmitz G, Fischer H, Beuck M, Hoecker K-P, Robenek H. Dysregulation of lipid metabolism in Tangier-monocyte derived macrophages. Arteriosclerosis. 1990;10:1010-1019.
21. 2+ system in HL60 leukemia cells. FEBS Lett. 1996;379:260-264.
22. Venable ME, Bielawska A, Obeid LM. Ceramide inhibits phospholipase D in a cell-free system. J Biol Chem. 1996;271:24800-24805.
23. Abousalham A, Liossis C, O'Brien L, Brindley DN. Cell-permeable ceramides prevent the activation of phospholipase D by ADP-ribosylation factor and RhoA. J Biol Chem. 1997;272:1069-1075.
24. Linardic CM, Jayadev S, Hannun YA. Activation of the sphingomyelin cycle by brefeldin A: effects of brefeldin A on differentiation and implications for a role for ceramide in regulation of protein trafficking. Cell Growth Differ. 1996;7:765-774.
25. Rani CS, Abe A, Chang Y, Rosenzweig N, Saltiel AR, Radin NS, Shayman JA. Cell cycle arrest induced by an inhibitor of glucosylceramide synthase: correlation with cyclin-dependent kinases. J Biol Chem. 1995;270:2859-2867.
26. Jayadev S, Liu B, Bielawska AE, Lee JY, Nazaire F, Pushkareva M Yu, Obeid LM, Hannun YA. Role for ceramide in cell cycle arrest. J Biol Chem. 1995;270:2047-2052.
27. Fogelman AM, Seager J, Hokom M, Edwards PA. Separation of and cholesterol synthesis by human lymphocytes and monocytes. J Lipid Res. 1979;20:379-388.
28. Vindelov LL, Christensen IJ, Nissen NI. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry. 1983;3:323-327.
29. Rabinovitsch PS. DNA content histogram and cell cycle analysis. Methods Cell Biol. 1994;41:263-296.
30. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Phys. 1959;37:911-917.
31. Motta S, Monti M, Sesana S, Mellesi L, Ghidomi R, Caputo R. Abnormality of water barrier function in psoriasis: role of ceramide fractions. Arch Dermatol. 1994;130:452-456.
32. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olsen BJ, Klenk DC. Measurement of protein using bicinchoninic acid. Anal Biochem. 1985;150: 76-85.
33. Girschik P, Jakobs KH. ADP-ribosylation of signal transducing guanine nucleotide-binding proteins by cholera and pertussis toxin. In: Herhen H, Hucho F, eds. Handbook of Experimental Pharmacology: Selective Neurotoxicity. Berlin/Heidelberg/New York: Springer: 1991;102:807-816.
34. Heller M. Phospholipase D. Adv Lipid Res. 1978;16:267-326.
35. Mollenhauer HH, Morre DJ, Rowe LD. Alteration of intracellular traffic by monensin: mechanism, specificity and relationship to toxicity. Biochim Biophys Acta. 1990;1031:225-246.
36. Klausner RD, Donaldson JG, Lippincott-Schwartz J. Brefeldin A: insights into the control of membrane traffic and organelle structure. J Cell Biol. 1992;116:1071-1080.
37. Kambouris AM, Roach PD, Calvert GD, Nestel PJ. Retroendocytosis of high density lipoproteins by the human hepatoma cell line, HepG2. Arteriosclerosis. 1990;10:582-590.
38. Mori T, Takahashi K, Naito M, Kodama T, Hakamata H, Sakai M, Miyazaki A, Horiuchi S, Ando M. Endocytic pathway of scavenger receptors via trans-Golgi system in bovine alveolar macrophages. Lab Invest. 1994;71:409-416.
39. Madison KC, Howard EJ. Ceramides are transported through the Golgi apparatus in human keratinocytes in vitro. J Invest Dermatol. 1996;106: 1030-1035.
40. Mendez AJ. Monensin and brefeldin A inhibit high density lipoprotein-mediated cholesterol efflux from cholesterol enriched cells: implications for intracellular cholesterol transport. J Biol Chem. 1995;270:5891-5900.
41. Obeid LM, Hannun YA. Ceramide: a stress signal and mediator of growth suppression and apoptosis. J Cell Biochem. 1995;58:191-198.
42. Liscovitsch M. Phospholipase D: role in signal transduction and membrane traffic. J Lipid Mediat Cell Signal. 1996;14:215-221.
43. Boarder MR. A role for phospholipase D in control of mitogenesis. Trends Pharmacol Sci. 1994;15:57-62.
44. Lee CM, Haun RS, Tsai SC, Moss J, Vaughan M. Characterization of the human gene encoding ADP-ribosylation factor 1, a guanine nucleotide-binding activator of cholera toxin. J Biol Chem. 1992;267:9028-9034.
45. Tsai SC, Haun RS, Tsuchiya M, Moss J, Vaughan M. Isolation and characterization of the human gene for ADP-ribosylation factor 3, a 20-kDa guanine nucleotide-binding protein activator of cholera toxin. J Biol Chem. 1991;266:23053-23059.
46. Dickeson SK Jr, Helmkamp GM, Yarbrough LR. Sequence of a human cDNA encoding phosphatidylinositol transfer protein and occurrence of a related sequence in widely divergent eukaryotes. Gene. 1994;142: 301-305.
47. Tanaka S, Yamashita S, Hosaka K. Cloning and expression of human cDNA encoding phosphatidylinositol transfer protein-β. Biochim Biophys Acta. 1995;1259:199-202.
48. Spiegel S, Foster D, Kolesnick R. Signal transduction through lipid second messengers. Curr Opin Cell Biol. 1996;8:159-167.
49. Parton RG, Caveolae and caveolins. Curr Opin Cell Biol. 1996;8: 542-548.
50. Conrad PA, Smart EJ, Ying YS, Anderson RG, Bloom GS. Caveolin cycles between plasma membrane caveolae and the Golgi complex by microtubule-dependent and microtubule-independent steps. J Cell Biol. 1995;131:1421-1433.
51. Fielding CJ, Fielding PE Intracellular cholesterol transport. J Lipid Res. 1997;38:1503-1521.